Yahoo Web Search

Search results

  1. Aug 31, 2024 · Intraoperative cell salvage (ICS) reduces blood loss mainly by collecting blood during surgery. Blood is mixed with anticoagulants and sucked into the blood reservoir through negative pressure suction for filtration, after which high-speed centrifugal washing of the filtered blood is performed.

  2. Sep 7, 2024 · Updated strategies to manage blood salvage; Use of minimally invasive procedures to reduce perioperative bleeding and need for blood transfusion; Strategies for blood conservation associated with extracorporeal membrane oxygenation and cardiopulmonary perfusion;

    • Freelance writer and reviewer, Medscape, LLC
  3. 6 days ago · Autologous transfusion of blood salvaged intra-operatively (cell salvage) reduces the requirement for post-operative allogenic transfusion. Allogenic transfusion is associated with risks, and blood is a scarce and costly resource. However, the cost of cell salvage in liver resection has not been previously estimated.

  4. Aug 31, 2024 · Previous studies have reported that multimodal patient blood management (PBM) strategies were associated with a smaller effect of intraoperative cell salvage (ICS) in unilateral total hip arthroplasty. However, there are few studies on the role of ICS in SI-THA.

  5. 6 days ago · Erythropoiesis-stimulating agents should not be used before vascular or cardiac surgery, and autologous blood donation or salvage is not cost efficient. Research generally supports use of a lower threshold for red blood cell transfusion vs traditional standards.

  6. 3 days ago · The effectiveness of rituximab in the treatment of iTTP was first reported in 2002 in a case series of 3 patients with plasma-refractory iTTP. 68 Soon thereafter, rituximab was increasingly used in TTP in association with plasma exchange and corticosteroids, with clinical trial data confirming the efficacy first as a salvage therapy and then as ...

  7. 2 days ago · In the UK study, cell salvage in cesarean section compared to no cell salvage incurred $13,714 per donor blood transfusion avoided, and was therefore unlikely to be cost-effective . In the USA study, a broader study perspective, longer time horizon, and higher effectiveness estimates were used [ 84 ].

  1. People also search for